Screening for anxiety and depression in cancer patients: the effects of disease and treatment.

2.50
Hdl Handle:
http://hdl.handle.net/10541/97238
Title:
Screening for anxiety and depression in cancer patients: the effects of disease and treatment.
Authors:
Ibbotson, T; Maguire, Peter; Selby, P; Priestman, T; Wallace, L
Abstract:
The General Health Questionnaire 28 (GHQ 28), Hospital Anxiety and Depression Scale (HADS), and Rotterdam Symptom Checklist (RSCL) seemed promising in their ability to detect anxiety and depression in cancer patients. To compare their screening performance, 513 patients were recruited from four cancer centres, and visited at home by a trained interviewer. Paired combinations of questionnaires (GHQ 28 + HADS, GHQ 28 + RSCL or RSCL+HADS) were used, and then the Psychiatric Assessment Schedule was administered to enable a psychiatric diagnosis to be made using DSM III diagnostic criteria. A receiver operating characteristics curve was drawn by plotting the true positive rate (sensitivity) against the false positive rate (1-specificity) for each possible score on each questionnaire. In the overall sample, the HADS and RSCL performed well comparably. The HADS did best in those free of disease and when the disease was judged to be stable. Only the RSCL performed well in those with progressive disease. Both the HADS and RSCL were effective in those on treatment. The GHQ was superior to the RSCL in those off treatment. The choice of questionnaire and threshold score should take disease and treatment status into account, but all three questionnaires have a definite role in screening out anxiety and depression.
Affiliation:
CRC Psychological Medicine Group, Christie Hospital, Manchester, U.K.
Citation:
Screening for anxiety and depression in cancer patients: the effects of disease and treatment. 1994, 30A (1):37-40 Eur. J. Cancer
Journal:
European Journal of Cancer
Issue Date:
1994
URI:
http://hdl.handle.net/10541/97238
DOI:
10.1016/S0959-8049(05)80015-2
PubMed ID:
8142161
Type:
Article
Language:
en
ISSN:
0959-8049
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorIbbotson, Ten
dc.contributor.authorMaguire, Peteren
dc.contributor.authorSelby, Pen
dc.contributor.authorPriestman, Ten
dc.contributor.authorWallace, Len
dc.date.accessioned2010-04-23T10:11:22Z-
dc.date.available2010-04-23T10:11:22Z-
dc.date.issued1994-
dc.identifier.citationScreening for anxiety and depression in cancer patients: the effects of disease and treatment. 1994, 30A (1):37-40 Eur. J. Canceren
dc.identifier.issn0959-8049-
dc.identifier.pmid8142161-
dc.identifier.doi10.1016/S0959-8049(05)80015-2-
dc.identifier.urihttp://hdl.handle.net/10541/97238-
dc.description.abstractThe General Health Questionnaire 28 (GHQ 28), Hospital Anxiety and Depression Scale (HADS), and Rotterdam Symptom Checklist (RSCL) seemed promising in their ability to detect anxiety and depression in cancer patients. To compare their screening performance, 513 patients were recruited from four cancer centres, and visited at home by a trained interviewer. Paired combinations of questionnaires (GHQ 28 + HADS, GHQ 28 + RSCL or RSCL+HADS) were used, and then the Psychiatric Assessment Schedule was administered to enable a psychiatric diagnosis to be made using DSM III diagnostic criteria. A receiver operating characteristics curve was drawn by plotting the true positive rate (sensitivity) against the false positive rate (1-specificity) for each possible score on each questionnaire. In the overall sample, the HADS and RSCL performed well comparably. The HADS did best in those free of disease and when the disease was judged to be stable. Only the RSCL performed well in those with progressive disease. Both the HADS and RSCL were effective in those on treatment. The GHQ was superior to the RSCL in those off treatment. The choice of questionnaire and threshold score should take disease and treatment status into account, but all three questionnaires have a definite role in screening out anxiety and depression.en
dc.language.isoenen
dc.subjectCanceren
dc.subject.meshAdolescent-
dc.subject.meshAdult-
dc.subject.meshAged-
dc.subject.meshAged, 80 and over-
dc.subject.meshAnxiety-
dc.subject.meshDepression-
dc.subject.meshHumans-
dc.subject.meshMass Screening-
dc.subject.meshMiddle Aged-
dc.subject.meshNeoplasms-
dc.subject.meshPredictive Value of Tests-
dc.subject.meshPsychiatric Status Rating Scales-
dc.subject.meshSensitivity and Specificity-
dc.titleScreening for anxiety and depression in cancer patients: the effects of disease and treatment.en
dc.typeArticleen
dc.contributor.departmentCRC Psychological Medicine Group, Christie Hospital, Manchester, U.K.en
dc.identifier.journalEuropean Journal of Canceren

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.